Clavey V - Search Results

1

Structural domain of apolipoprotein A-I involved in its interaction with cells.

Luchoomun J, Theret N, Clavey V, Duchateau P, Rosseneu M, Brasseur R, Denefle P, Fruchart JC, Castro GR. Luchoomun J, et al. Among authors: clavey v. Biochim Biophys Acta. 1994 Jun 2;1212(3):319-26. doi: 10.1016/0005-2760(94)90206-2. Biochim Biophys Acta. 1994. PMID: 7515279

2

Immunochemical characterization of two antigenic sites on human apolipoprotein A-I; localization and lipid modulation of these epitopes.

Pio F, De Loof H, Vu Dac N, Clavey V, Fruchart JC, Rosseneu M. Pio F, et al. Among authors: clavey v. Biochim Biophys Acta. 1988 Mar 25;959(2):160-8. doi: 10.1016/0005-2760(88)90027-6. Biochim Biophys Acta. 1988. PMID: 2450589

3

HDL3 binds to glycosylphosphatidylinositol-anchored proteins to activate signalling pathways.

Nazih-Sanderson F, Lestavel S, Nion S, Rouy D, Denefle P, Fruchart JC, Clavey V, Delbart C. Nazih-Sanderson F, et al. Among authors: clavey v. Biochim Biophys Acta. 1997 Aug 21;1358(1):103-12. doi: 10.1016/s0167-4889(97)00055-4. Biochim Biophys Acta. 1997. PMID: 9296527 Free article.

4

Branched synthetic peptide constructs mimic cellular binding and efflux of apolipoprotein AI in reconstituted high density lipoproteins.

Nion S, Demoor L, Boutillon C, Luchoomun J, Vanloo B, Fievet C, Castro G, Rosseneu M, Fruchart JC, Tartar A, Clavey V. Nion S, et al. Among authors: clavey v. Atherosclerosis. 1998 Dec;141(2):227-35. doi: 10.1016/s0021-9150(98)00176-2. Atherosclerosis. 1998. PMID: 9862171

5

Early-glycation of apolipoprotein E: effect on its binding to LDL receptor, scavenger receptor A and heparan sulfates.

Laffont I, Shuvaev VV, Briand O, Lestavel S, Barbier A, Taniguchi N, Fruchart JC, Clavey V, Siest G. Laffont I, et al. Among authors: clavey v. Biochim Biophys Acta. 2002 Jun 13;1583(1):99-107. doi: 10.1016/s1388-1981(02)00188-9. Biochim Biophys Acta. 2002. PMID: 12069854

6

Apolipoprotein A-II, HDL metabolism and atherosclerosis.

Tailleux A, Duriez P, Fruchart JC, Clavey V. Tailleux A, et al. Among authors: clavey v. Atherosclerosis. 2002 Sep;164(1):1-13. doi: 10.1016/s0021-9150(01)00751-1. Atherosclerosis. 2002. PMID: 12119188 Review.

7

Regulation of the scavenger receptor BI and the LDL receptor by activators of aldosterone production, angiotensin II and PMA, in the human NCI-H295R adrenocortical cell line.

Pilon A, Martin G, Bultel-Brienne S, Junquero D, Delhon A, Fruchart JC, Staels B, Clavey V. Pilon A, et al. Among authors: clavey v. Biochim Biophys Acta. 2003 Apr 8;1631(3):218-28. doi: 10.1016/s1388-1981(03)00020-9. Biochim Biophys Acta. 2003. PMID: 12668173

8

Human free apolipoprotein A-I and artificial pre-beta-high-density lipoprotein inhibit eNOS activity and NO release.

Briand O, Nizard FM, David-Dufilho M, Six I, Lestavel S, Brunet A, Fruchart JC, Torpier G, Bordet R, Clavey V, Duriez P. Briand O, et al. Among authors: clavey v. Biochim Biophys Acta. 2004 Jul 5;1683(1-3):69-77. doi: 10.1016/j.bbalip.2004.04.007. Biochim Biophys Acta. 2004. PMID: 15238221

9

Isolation and characterization of two sub-species of Lp(a), one containing apo E and one free of apo E.

Bard JM, Delattre-Lestavel S, Clavey V, Pont P, Derudas B, Parra HJ, Fruchart JC. Bard JM, et al. Among authors: clavey v. Biochim Biophys Acta. 1992 Jul 29;1127(2):124-30. doi: 10.1016/0005-2760(92)90267-y. Biochim Biophys Acta. 1992. PMID: 1322706

10

[Interaction between LDL receptor and lipoproteins containing apo B].

Clavey V, Agnani G, Bard JM, Lestavel-Delattre S, Fruchart JC. Clavey V, et al. Ann Endocrinol (Paris). 1991;52(6):459-63. Ann Endocrinol (Paris). 1991. PMID: 1824499 French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

74 results

Search Page

Filters